Category Archives: Cancer: Multiple Myeloma

Low Intensity Vibration Mitigates Tumor Progression and Protect Bone Quantity and Quality in a Murine Model of Myeloma






Bone. 2016 Jun 1. pii: S8756-3282(16)30150-8. doi: 10.1016/j.bone.2016.05.014. [Epub ahead of print] Low Intensity Vibration Mitigates Tumor Progression and Protect Bone Quantity and Quality in a Murine Model of Myeloma. Pagnotti GM1, Chan ME1, Adler BJ1, Shroyer KR2, Rubin J3, … Continue reading






Posted in Cancer: Multiple Myeloma | Leave a comment

For multiple myeloma, FDA approves Ninlaro, new oral medication






Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy. Multiple myeloma is a form of blood cancer … Continue reading






Posted in Cancer: Multiple Myeloma | Comments Off on For multiple myeloma, FDA approves Ninlaro, new oral medication

Father’s age linked to risk of blood cancer as an adult; particularly strong among only children: American Cancer Society






A new study links a father’s age at birth to the risk that his child will develop blood and immune system cancers as an adult, particularly for only children. The study, which appears in the American Journal of Epidemiology, found … Continue reading






Posted in Cancer: Leukemia, Cancer: Lymphoma, Cancer: Multiple Myeloma, Immune System | Comments Off on Father’s age linked to risk of blood cancer as an adult; particularly strong among only children: American Cancer Society

Multiple myeloma and myeloid leukemia therapies could be enhanced with experimental drug






A pre-clinical study led by Virginia Commonwealth University Massey Cancer Center and Department of Internal Medicine researchers suggests that an experimental drug known as dinaciclib could improve the effectiveness of certain multiple myeloma and myeloid leukemia therapies. The study, recently … Continue reading






Posted in Cancer: Leukemia, Cancer: Multiple Myeloma | Comments Off on Multiple myeloma and myeloid leukemia therapies could be enhanced with experimental drug

Alcohol consumption tied to reduced cancer risk in new, large study






Cancer Epidemiol Biomarkers Prev. 2013 Aug 20. [Epub ahead of print] A Pooled Analysis of Alcohol Consumption and Risk of Multiple Myeloma in the International Multiple Myeloma Consortium. Andreotti G, Birmann B, De Roos AJ, Spinelli J, Cozen W, Camp … Continue reading






Posted in Alcohol, Cancer: Multiple Myeloma | Comments Off on Alcohol consumption tied to reduced cancer risk in new, large study

Multiple myeloma drug Kyprolis gets FDA approval






The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises … Continue reading






Posted in Cancer: Multiple Myeloma | Comments Off on Multiple myeloma drug Kyprolis gets FDA approval